Form D/A — Zakara Biotechnology Fund LP
0000919574-26-002327 · filed Apr 22, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Reported offering amount
- —
- Reported amount sold
- $15,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Zakara Biotechnology Fund LP
- CIK
- 2058789
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 300 PARK AVENUE
NEW YORK, NY 10022 - Phone
- 646 419 8761
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- Zakara Capital LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
- Zakara Biotechnology Fund GP LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Janet Okogbaa · Executive OfficerNew York, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗